BC Partners is nearing a deal to sell Dutch generic drugmaker Synthon International Holding BV to Goldman Sachs Asset Management, according to people familiar with the matter.
BC Partners Nears Sale of Synthon to Goldman Asset Arm
Estimated read time
1 min read
You May Also Like
More From Author
Christmas forecasted to be mild for most
December 24, 2024
Your VASP License Isn’t Enough Anymore
December 24, 2024
Olympic Snowboarder Sophie Hediger Dead At 26, Killed In Avalanche
December 24, 2024
+ There are no comments
Add yours